Research graph
References from Corrigendum to “Triazolo[4,5- d ]pyrimidines as validated general control nonderepressible 2 (GCN2) protein kinase inhibitors reduce growth of leukemia cells” [Comput. Struct. Biotechnol. J. 16 (2018) 350–360]. Local targets link to admitted publications; unresolved targets remain external evidence.
